Theresa P. Pretlow - Concepedia

Author

Theresa P. Pretlow

Also Known As

Bin Yang, Carrie M. Delmoro, Pretlow, Theresa P., T P Pretlow, T P Pretlow II, T Pretlow, T. P. Pretlow, T.P. Pretlow, THERESA P. PRETLOW, Theresa P Pretlow

106

Publications

8.3K

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University University School University of Alabama at Birmingham University Hospitals of Cleveland Howard Hughes Medical Institute

About

Theresa P. Pretlow is an author at Case Western Reserve University specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	40	4.9K
2	Natural Sciences	3	3	89
3	Engineering	1	1	23
4	Health Sciences	1	1	106
5	Allergy	1	1	38

Theresa P. Pretlow

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Hiromu Suzuki, D. Neil Watkins, Kam-Wing Jair, Nature Genetics Sfrp GenesRadiation OncologyMedicineEpigenetic InactivationColorectal Cancer	2004	1.1K
A new human prostate carcinoma cell line, 22Rv1 R. Michael Sramkoski, Thomas G. Pretlow, Joseph M. Giaconia, In Vitro Cellular & Developmental Biology - Animal UrologyGenitourinary CancerProstatic DiseaseMedicineTumor Biology	1999	588
Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Theresa P. Pretlow, B J Barrow, W S Ashton, PubMed MedicinePathogenesisImmunologyGastroenterologyPathology	1991	449
Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene Wei-Dong Chen, Zhifen Han, Joel Skoletsky, JNCI Journal of the National Cancer Institute	2005	368
<i>SLC5A8</i> , a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers Hui Li, Lois L. Myeroff, Dominic J. Smiraglia, Proceedings of the National Academy of Sciences Slc5a8 ExpressionEpigenetic ChangeGeneticsSlc5a8 TranscriptCancer Biology	2003	293
Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate Theresa P. Pretlow, Mary Ann O’Riordan, Gregory A. Somich, Carcinogenesis Tumor BiologyF344 RatsChemoprevention StrategyOncogenic AgentTumor Incidence	1992	282
15-Hydroxyprostaglandin dehydrogenase is an <i>in vivo</i> suppressor of colon tumorigenesis Seung‐Jae Myung, Ronald M. Rerko, Min Yan, Proceedings of the National Academy of Sciences	2006	250
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. M. Nagabhushan, Charles M. Miller, Theresa P. Pretlow, PubMed Prostate CancersEndocrine OncologyUrologySoft AgarProstate Cancer Xenografts	1996	239
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Mark A. Wainstein, Fei He, Dan R. Robinson, PubMed Tumor BiologyUrologyLong-term PropagationAndrogen-dependent Xenograft ModelPrimary Human Pca	1994	225
K-ras Mutations in Putative Preneoplastic Lesions in Human Colon Theresa P. Pretlow, Thomas A. Brasitus, Noreen Fulton, JNCI Journal of the National Cancer Institute	1993	223

Page 1